SEL ICB Lambeth Community Denosumab Service

CPV: Services provided by medical personnel

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Yes (GPA)

Recurring procurement

Unspecified in notice

First published

28 Apr 2026, 11:40 BST

Last source update

29 Jul 2026, 14:05 BST

FTS notice number

2026/S 000-071732

Classification (CPV)

Services provided by medical personnel

Delivery area

London (UKI45)

Official registry OCID

ocds-h6vhtk-068c80 Find a Tender

Why no open competition

No tenders or no suitable tenders/requests to participate in response to open procedure

Published justification

Justification: Award of a contract without prior publication of a call for competition in the cases listed below

Reason: The procurement falls outside the scope of application of the regulations

Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: [email protected] Award Decision makers: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care There was no conflict of interest identified in the decision-making process. Evaluation Criteria and Weighting Scoring from 0-4, with percentage allocation based on the importance of the criteria in the service requirement. Key criteria: Quality and Innovation: 20% Value for Money: 25% Integration, Collaboration and Service Sustainability: 20% Improving Access, Reducing Health Inequalities and Facilitating Choice: 25% Social Value: 10% The criteria were applied with their respective weightings as specified, with scoring against a number of sub-categories for each criterion. An assessment against current and future performance for these individual sub-categories was undertaken, resulting in a combined overall score out of 100%. The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: [email protected] and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed. This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (PSR). No conflicts of interest were identified in the decision-making process. Decision Makers and Dates of Decision The decision to proceed with the intention to award was made by: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care Lambeth Together Planning and Finance Group - 23 March 2026 Lambeth Together Senior Management Team - 31 March 2026 Rationale for Selection of Current Provider The current provider has demonstrated sustained high-quality performance and value for money, including: Maintaining 100% performance across key service standards, including: -Provision of service to all appropriately referred patients -Contacting patients within 72 hours of referral from secondary care -Issuing patient reminder cards and information leaflets -Providing consistent feedback from service users and referring acute trusts -Reporting 0% near misses or incidents from both the provider and acute trust -Effective financial management, remaining within the agreed budget -Delivery in line with NICE TA204 (Denosumab for the prevention of osteoporotic fractures in postmenopausal women) -Alignment with the South East London Osteoporosis Pathway and the South East London Shared Care Agreement for Denosumab 60mg/ml -Supporting care closer to home and improved patient experience through community-based administration of treatment -Sustained achievement of ≥95% across key performance indicators, including: -Timely patient contact within 72 hours -Provision of patient information materials -Service user and referrer feedback mechanisms -Incident reporting compliance -Annual patient satisfaction feedback demonstrating good service experience

• Lambeth Healthcare LtdAwarded supplierGB-NHS: CQC Akerman Health Centre, Second Floor, 60 Patmos Road, London, London, SW9 6AFContact emailShow contact details

No document links were published on the notice.